STERIS plc
—- Market cap
- $21.30B
- Debt
- +$1.93B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $21.30B · View financials
Snapshot Sep 8, 2026, 4:00 PM ET
Decision snapshot: STE stock price at premium vs IIPR $218.44 current versus $115.44 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IIPR's multiple
Implied fair value · at STE's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: STE FY 2026 (ended Mar 31, 2026) · IIPR FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Capital structure 80% equity / 20% debt · EV / Revenue 7.23x · EV / EBITDA 9.22x
STE carries the larger enterprise value at $23.23B against $1.92B; STE trades on the lower EV / Revenue multiple (3.91x vs 7.23x); IIPR on the lower EV / EBITDA (9.22x vs 15.17x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STERIS plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Innovative Industrial Properties, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.27x
0.21x
Net debt / EBITDA
Leverage against operating earnings
—
1.66x
Cash and equivalents
Liquid reserves on the balance sheet
—
$47.60M
Total debt
Interest-bearing obligations outstanding
$1.93B
$393.72M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
STE vs JNJ
BAXTER INTERNATIONAL INC
STE vs BAX
BECTON DICKINSON & CO
STE vs BDX
ZIMMER BIOMET HOLDINGS, INC.
STE vs ZBH
REALTY INCOME CORP
STE vs O
AGREE REALTY CORP
STE vs ADC
HEALTHPEAK PROPERTIES, INC.
STE vs DOC
LTC PROPERTIES INC
STE vs LTC
Sabra Health Care REIT, Inc.
STE vs SBRA
OMEGA HEALTHCARE INVESTORS INC
STE vs OHI
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.